← All trials
NCT05845307
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2024
- Primary completion
- Feb 1, 2025
- Completion date
- Feb 1, 2025
- First posted
- May 6, 2023
- Last posted
- Nov 24, 2023
- Enrollment
- 33
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Texas at HoustonLead sponsor
- National Institutes of Health (NIH)Collaborator
- University of Texas at HoustonOverall official - principal investigator
- Tvardi Therapeutics, IncorporatedCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.